Phuong Do Thi, Ma Chao-Mei, Hattori Masao, Jin Jong Sik
Institute of Natural Medicine, University of Toyama, Sugitani 2630, Toyama 930-0194, Japan.
Phytother Res. 2009 Apr;23(4):582-4. doi: 10.1002/ptr.2657.
Antrodia cinnamomea is a highly valued folk medicine used for liver cancer, a disease often caused by the long term infection of hepatitis C virus (HCV). In the present study, the maleic and succinic acid constituents (antrodins A-E) of this medicinal fungus, the in vivo metabolites of antrodin C and the analogue of one of the metabolites were tested for their inhibitory activity on HCV protease. Most of the compounds showed potent inhibitory activity, with antrodin A being the most potent (IC(50) = 0.9 microg/mL). Antrodin A was isolated as one of the constituents of A. cinnamomea and was also detected as an in vivo metabolite of the major constituent antrodin C. The mode of inhibition for antrodin A on HCV protease was revealed by a Lineweaver-Burk plot as competitive inhibition. These results strongly support the use of this folk medicine for liver cancer and HCV infection which is a global problem.
樟芝是一种备受珍视的民间药物,用于治疗肝癌,肝癌通常由丙型肝炎病毒(HCV)长期感染引起。在本研究中,测试了这种药用真菌的马来酸和琥珀酸成分(樟芝菌素A-E)、樟芝菌素C的体内代谢产物以及其中一种代谢产物的类似物对HCV蛋白酶的抑制活性。大多数化合物表现出强效抑制活性,其中樟芝菌素A活性最强(IC(50) = 0.9微克/毫升)。樟芝菌素A作为樟芝的成分之一被分离出来,同时也被检测为主要成分樟芝菌素C的体内代谢产物。通过Lineweaver-Burk图揭示了樟芝菌素A对HCV蛋白酶的抑制模式为竞争性抑制。这些结果有力地支持了这种民间药物用于治疗肝癌和HCV感染,HCV感染是一个全球性问题。